Human Phenotype Ontology 
Grandparent Node:
expand
Abnormal myeloid leukocyte morphology (HP:0010974)help
Grandparent Node:
expand
Abnormality of connective tissue (HP:0003549)help
Parent Node:
expand
Abnormal mast cell morphology (HP:0100494)help
..Starting node
..expand
Increased proportion of CD25+ mast cells (HP:0031408)help
Term ID: 31408
Name: Increased proportion of CD25+ mast cells
Synonym:
Definition: An increased proportion of mast cells are positive for the cell surface marker CD25 (also called interleukin-2 receptor alpha chain).
Comments:
Reference: HP:0031408
Genes and Diseases:
 
       Child Nodes:

 Sister Nodes: 
..expandMastocytosis (HP:0100495) help
InputHPO IDHPO termDistanceGeneGene id entrezHGNC IDDiseaseIdDiseaseNameFrequencyOnsetHGMD variantsClinVar variants
 
HPO disease - gene - phenotype typical associations:
 
HPO disease - gene - phenotype less frequent non-typical associations:
HP:0031408HP:0031408Increased proportion of CD25+ mast cells0ASXL1 CL E G H17102318318ORPHA:98850Aggressive systemic mastocytosisHP:0040282 - Frequent145
HP:0031408HP:0031408Increased proportion of CD25+ mast cells0CBL CL E G H8671541ORPHA:98850Aggressive systemic mastocytosisHP:0040282 - Frequent317
HP:0031408HP:0031408Increased proportion of CD25+ mast cells0LYST CL E G H11301968ORPHA:167Chédiak-Higashi syndromeHP:0040281 - Very frequent239
HP:0031408HP:0031408Increased proportion of CD25+ mast cells0RUNX1 CL E G H86110471ORPHA:98850Aggressive systemic mastocytosisHP:0040282 - Frequent181
HP:0031408HP:0031408Increased proportion of CD25+ mast cells0SRSF2 CL E G H642710783ORPHA:98850Aggressive systemic mastocytosisHP:0040282 - Frequent1
HP:0031408HP:0031408Increased proportion of CD25+ mast cells0TET2 CL E G H5479025941ORPHA:98850Aggressive systemic mastocytosisHP:0040282 - Frequent3


Genes (6) :ASXL1 CBL LYST RUNX1 SRSF2 TET2

Diseases (2) :ORPHA:98850 ORPHA:167
 

Human Phenotype Ontology(HPO) is developed by the Human Phenotype Ontology Consortium. The version used here is December 15 2022 release.